Warwick Effect Polymers (WEP) is a UK-based polymer specialist company developing and manufacturing novel functional polymers for high value applications. Using proprietary technologies and expertise based on controlled polymerisation, WEP designs, develops and manufactures novel polymers to meet the specific requirements of the Pharmaceutical, Biotechnology and Speciality Polymer Industry sectors. WEP was acquired by PolyTherics Limited in January 2012. For further information please go to hhtp://www.polytherics.co.uk
PolyPEG® offers a novel approach to half-life extension for biological therapeutics.
GlycoPol™ is a novel range of glycopolymers that can be structurally tuned for targeted delivery of therapeutics.
WEP’s proprietary technology allows controlled synthesis of polymers including block and graft copolymers.
